daclizumab
Showing 1 - 25 of 45
Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)
Terminated
- Aplastic Anemia
- +2 more
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)
Completed
- Kidney Transplantation
- +2 more
- Campath
- Daclizumab
-
London, United KingdomWest London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021
DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,
Completed
- DiGeorge Anomaly
- +4 more
- Cultured Thymus Tissue for Implantation (CTTI)
- +8 more
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- +3 more
- daclizumab
- +4 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Worldwide (Daclizumab)
Terminated
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- Daclizumab
-
Tampa, Florida
- +10 more
Sep 25, 2019
Kidney Failure, Chronic Trial in Baltimore (Thymoglobulin, Daclizumab, Plasmapheresis)
Completed
- Kidney Failure, Chronic
- Thymoglobulin
- +7 more
-
Baltimore, MarylandThe Johns Hopkins University, School of Medicine
Dec 19, 2017
Transplant; Failure, Kidney Trial in Miami (Alemtuzumab, Daclizumab, Thymoglobulin)
Completed
- Transplant; Failure, Kidney
- Alemtuzumab
- +2 more
-
Miami, FloridaUniversity of Miami Miller School of Medicine
Nov 5, 2017
Uveitis Trial run by the NEI (Daclizumab)
Completed
- Uveitis
- Daclizumab
-
Bethesda, MarylandNational Eye Institute (NEI)
Jun 30, 2017
HIV Trial run by the NIAID (Daclizumab)
Completed
- HIV Infections
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Uveitis Trial run by the NEI (Daclizumab)
Completed
- Uveitis
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Non-infectious Intermediate and Posterior Uveitis Trial run by the NEI (Daclizumab)
Completed
- Non-infectious Intermediate and Posterior Uveitis
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Multiple Sclerosis, Relapsing-Remitting Trial run by the NINDS (Daclizumab)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Anterior Uveitis, Arthritis, Juvenile Idiopathic, Iritis Trial run by the NEI (Daclizumab)
Completed
- Anterior Uveitis
- +3 more
- Daclizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 27, 2017
GVHD Trial in United States (Daclizumab, methylprednisolone, Placebo)
Completed
- Graft Versus Host Disease
- Daclizumab
- +2 more
-
Boston, Massachusetts
- +7 more
Jan 19, 2017
Heart Transplantation Trial in Spain (Daclizumab, Mycophenolate mofetil, Silrolimus)
Completed
- Heart Transplantation
- Daclizumab
- +2 more
-
Barcelona, Spain
- +13 more
Nov 1, 2016
Diabetes, Insulin-Dependent Trial in Worldwide (Islet Transplantation, Sirolimus, Tacrolimus)
Completed
- Diabetes Mellitus, Insulin-Dependent
- Islet Transplantation
- +7 more
-
Miami, Florida
- +8 more
Feb 6, 2017
Kidney Diseases, Kidney Transplantation, Kidney Transplant Trial in United States (Daclizumab, Mycophenolate mofetil (MMF),
Completed
- Kidney Diseases
- +4 more
- Daclizumab
- +6 more
-
Birmingham, Alabama
- +11 more
Oct 19, 2016
Amount of Medications That May be Removed From Body During
Withdrawn
- Kidney Transplantation
- Plasmapheresis
- tacrolimus
- +4 more
-
New York, New York
- +1 more
Oct 19, 2016
End-Stage Renal Disease Trial in Rockville (Daclizumab, Methylprednisolone/prednisone, Mycophenolate mofetil)
Completed
- End-Stage Renal Disease
- Daclizumab
- +6 more
-
Rockville, MarylandLauren Schenker
Oct 19, 2016
End Stage Renal Disease Trial in Charleston (Rabbit Antithymocyte globulin, Daclizumab)
Completed
- End Stage Renal Disease
- Rabbit Antithymocyte globulin
- Daclizumab
-
Charleston, South CarolinaMedical University of South Carolina
Mar 23, 2016
Type 1 Diabetes Trial in Philadelphia (Allogeneic Pancreatic Islet Cells, Antithymocyte globulin, Daclizumab)
Terminated
- Type 1 Diabetes Mellitus
- Allogeneic Pancreatic Islet Cells
- +4 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 21, 2016
Cardiac Transplantation Trial in Houston (Daclizumab)
Terminated
- Cardiac Transplantation
- Daclizumab
-
Houston, TexasBaylor College of Medicine
Oct 14, 2015
Heart Transplantation Trial in Worldwide (Daclizumab, Methylprednisolone, Mycophenolate mofetil)
Completed
- Heart Transplantation
- Daclizumab
- +4 more
-
Birmingham, Alabama
- +29 more
May 4, 2016
Malignant Tumors of Brain Trial in Durham (biological, drug, other)
Completed
- Malignant Neoplasms of Brain
- PEP-3-KLH conjugate vaccine
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Jan 20, 2016